dEsparbes Eric 4
4 · BIORA THERAPEUTICS, INC. · Filed May 17, 2022
Insider Transaction Report
Form 4
dEsparbes Eric
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-15+472,495→ 472,495 totalExercise: $0.75Exp: 2032-05-15→ Common Stock (472,495 underlying) - Tax Payment
Common Stock
2022-05-15$0.75/sh−10,387$7,790→ 412,784 total - Award
Common Stock
2022-05-15+292,406→ 705,190 total
Footnotes (3)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 20,948 vested restricted stock units on May 15, 2022.
- [F2]Consists of 292,406 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
- [F3]This option represents the right to purchase 472,495 shares of the Issuer's common stock, 9,843 of which vested upon grant, with the remaining shares vesting in equal monthly installments through April 15, 2026, subject to the Reporting Person's continued service to the Issuer.